EUVIMEDEUVIMED entdecken
Crossref

Outcomes and atrial substrate analysis in patients with HIV undergoing atrial fibrillation ablation

Austin Cheng, Jessica Qiu, Chirag Barbhaiya, Leonid Garber, Douglas Holmes, Lior Jankelson, Alexander Kushnir, Robert Knotts, Scott Bernstein, David Park, Michael Spinelli, Larry Chinitz iD und 1 weitere

Journal of Cardiovascular Electrophysiology · 2023-03 · 34 (3) · 575-582

DOI: 10.1111/jce.15774 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 16.12.2022. Verfasst von Austin Cheng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Leon H. Charney Division of Cardiology, Cardiac Electrophysiology, NYU Langone Health, New York University Grossman School of Medicine, New York, New…. Hauptthemen laut MEDLINE: Atrial Fibrillation, HIV Infections, Tachycardia, Supraventricular, Pulmonary Veins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Patients with HIV infection have increased risk of atrial fibrillation, but the pathophysiologic mechanisms and the utility of catheter ablation in this population are not well‐studied. We aimed to characterize outcomes of atrial fibrillation ablation and left atrial substrate in patients with HIV.

Methods

The study was a retrospective propensity score‐matched analysis of patients with and without HIV undergoing atrial fibrillation ablation. A search was performed in the electronic medical record for all patients with HIV who received initial atrial fibrillation ablation from 2011 to 2020. After calculating propensity scores for HIV, matching was performed with patients without HIV by using nearest‐neighbor matching without replacement in a 1:2 ratio. The primary outcome was freedom from atrial arrhythmia and secondary outcomes were freedom from atrial fibrillation, freedom from atrial tachycardia, and freedom from repeat ablation, compared by log‐rank analysis. The procedures of patients with HIV who underwent repeat ablation at our institution were further analyzed for etiology of recurrence. To further characterize the left atrial substrate, a subsequent case‐control analysis was then performed for a set of randomly chosen 10 patients with HIV matched with 10 without HIV to compare minimum and maximum voltage at nine pre‐specified regions of the left atrium.

Results

Twenty‐seven patients with HIV were identified. All were prescribed antiretroviral therapy at time of ablation. These patients were matched with 54 patients without HIV by propensity score. 86.4% of patients with HIV and 76.9% of controls were free of atrial fibrillation or atrial tachycardia at 1 year ( p = .509). Log‐rank analysis showed no difference in freedom from atrial arrhythmia ( p value .971), atrial fibrillation ( p ‐value .346), atrial tachycardia ( p value .306), or repeat ablation ( p value .401) after initial atrial fibrillation ablation in patients with HIV compared to patients without HIV. In patients with HIV with recurrent atrial fibrillation, the majority had pulmonary vein reconnection (67%). There were no significant differences in minimum or maximum voltage at any of the nine left atrial regions between the matched patients with and without HIV.

Conclusions

Ablation to treat atrial fibrillation in patients with HIV, but without overt AIDS is frequently successful therapy. The majority of patients with recurrence of atrial fibrillation had pulmonary vein reconnection, suggesting infrequent nonpulmonary vein substrate. In this population, the left atrial voltage in patients with HIV is similar to that of patients without HIV. These findings suggest that the pulmonary veins remain a critical component to the initiation and maintenance of atrial fibrillation in patients with HIV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHIV InfectionsTachycardia, SupraventricularPulmonary VeinsCatheter AblationHumansRetrospective StudiesTreatment OutcomeHeart AtriaRecurrence

Stichwörter der Autor:innen

HIVatrial fibrillationcatheter ablationfreedom from arrhythmialeft atrial voltage

Autor:innen und Institutionen

  • Leon H. Charney Division of Cardiology, Cardiac Electrophysiology, NYU Langone Health, New York University Grossman School of Medicine, New York, New York, USA.

ORCID-Profile: Larry Chinitz, Anthony Aizer

Zitieren

APA

Cheng, A., Qiu, J., Barbhaiya, C., Garber, L., Holmes, D., Jankelson, L., Kushnir, A., Knotts, R., Bernstein, S., Park, D., Spinelli, M., Chinitz, L., & Aizer, A. (2023). Outcomes and atrial substrate analysis in patients with HIV undergoing atrial fibrillation ablation. Journal of Cardiovascular Electrophysiology, 34(3), 575-582. https://doi.org/10.1111/jce.15774

Vancouver

Cheng A, Qiu J, Barbhaiya C, Garber L, Holmes D, Jankelson L, et al. Outcomes and atrial substrate analysis in patients with HIV undergoing atrial fibrillation ablation. Journal of Cardiovascular Electrophysiology. 2023;34(3):575-582. doi:10.1111/jce.15774

BibTeX
@article{Cheng2023,
  author = {Cheng, Austin and Qiu, Jessica and Barbhaiya, Chirag and Garber, Leonid and Holmes, Douglas and Jankelson, Lior and Kushnir, Alexander and Knotts, Robert and Bernstein, Scott and Park, David and Spinelli, Michael and Chinitz, Larry and Aizer, Anthony},
  title = {Outcomes and atrial substrate analysis in patients with HIV undergoing atrial fibrillation ablation},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2023},
  volume = {34},
  number = {3},
  pages = {575--582},
  doi = {10.1111/jce.15774}
}
Kostenlos starten →